Cited by 214Gut microbiota and healthAutism Spectrum Disorder ResearchChild Nutrition and Feeding Issues

The DOI matches its Crossref record; 202 of the 202 references it cites were found in a registry or an index; none of the 197 sources its claims cite is checked for support yet.

Autism, Gastrointestinal Symptoms and Modulation of Gut Microbiota by Nutritional Interventions

Open access

Abstract

Autism spectrum disorder (ASD) is a complex behavioral syndrome that is characterized by speech and language disorders, intellectual impairment, learning and motor dysfunctions. Several genetic and environmental factors are suspected to affect the ASD phenotype including air pollution, exposure to pesticides, maternal infections, inflammatory conditions, dietary factors or consumption of antibiotics during pregnancy. Many children with ASD shows abnormalities in gastrointestinal (GI) physiology, including increased intestinal permeability, overall microbiota alterations, and gut infection. Moreover, they are “picky eaters” and the existence of specific sensory patterns in ASD patients could represent one of the main aspects in hampering feeding. GI disorders are associated with an altered composition of the gut microbiota. Gut microbiome is able to communicate with brain activities through microbiota-derived signaling molecules, immune mediators, gut hormones as well as vagal and spinal afferent neurons. Since the diet induces changes in the intestinal microbiota and in the production of molecules, such as the SCFA, we wanted to investigate the role that nutritional intervention can have on GI microbiota composition and thus on its influence on behavior, GI symptoms and microbiota composition and report which are the beneficial effect on ASD conditions.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

This narrative review examines links among autism spectrum disorder (ASD), gastrointestinal symptoms, gut microbiota, and nutritional interventions. It concludes that food selectivity and altered microbiota/metabolite pathways may contribute to GI and behavioral symptoms, but evidence for specific diets remains limited.

Key findings

  • GI symptoms are common but variably reported in ASD, with prevalence ranging from 23% to 70%; in one study of 150 children, 70% of ASD children had GI symptoms versus 28% of typically developing children and 42% of children with other developmental disabilities, and studies of 140–170 ASD children found 24–63% had at least one GI symptom.
  • Food selectivity in ASD is driven by texture (69%), appearance (58%), taste (45%), smell (36%), temperature (22%), reluctance to try new foods (69%), and a small repertoire of accepted foods (60%); presentation factors were reported at 48.6% and utensil/tableware characteristics at 13.8%, and nearly 90% of preschool and school-age ASD children were reported not to process sensory information the same way as typically developing peers.
  • ASD children show altered gut microbiota profiles, including reduced relative abundance of *Prevotella*, *Coprococcus*, *Enterococcus*, *Lactobacillus*, *Streptococcus*, *Lactococcus*, *Staphylococcus*, *Ruminococcus*, and *Bifidobacterium*, and higher *Clostridia*, *Desulfovibrio*, *Sutterella*, and *Ruminococcus torques*; one study of 40 ASD and 40 non-ASD participants found *Candida* representation up to 2 times greater in ASD.
  • Proposed metabolite pathways include elevated acetic acid and propionic acid, lower butyric acid, increased SCFA-producing bacteria, and elevated whole-blood/platelet serotonin in approximately 30% of children with ASD; dietary evidence is mixed or limited for gluten-free/casein-free diet, ketogenic diet, and specific carbohydrate diet, and no studies were found on the Mediterranean diet in ASD patients.

Methods

  • Design: narrative literature review conducted on PubMed from 1955 to 2019 using terms including “autism,” “autism spectrum disorder,” “diet,” “nutritional status,” “microbiota,” “microbiome,” “metabolites,” “dysbiosis,” and “gastrointestinal symptoms.”
  • Inclusion criteria: observational prospective and retrospective studies, case–control studies, cohort studies, or systematic reviews; studies investigating gut microbiota profiles and metabolites in ASD children; studies with information on nutritional intervention or nutritional status in ASD patients; and studies written in English.
  • Analysis: qualitative synthesis of included literature; no meta-analysis or quantitative pooling is described.

Limitations

  • The paper states that evidence for gluten-free/casein-free diet is limited and inadequate in quantity, quality, and methodological rigor; ketogenic diet evidence is based on a limited number of reports and is insufficient to establish practicability; specific carbohydrate diet evidence comes from few studies, including one case report; and no studies were found on the Mediterranean diet in ASD patients.
  • The paper states that GI symptom prevalence varies widely due to differences in criteria, symptoms considered, data sources, reporting periods, and population characteristics, and that dietary data may be inaccurate because parental concern may influence reporting; it also states that the physiological processes linking food selectivity and GI problems remain difficult to decipher.
  • Evident from the text: as a narrative review, it does not report a systematic quality appraisal, risk-of-bias assessment, or meta-analysis, and many cited intervention findings are small, animal-based, or case-level.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/nu11112812

Cites

202 of 202 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Factors that could determine food selectivity (data taken from the studies of Williams, Schreck and Klein [52,53,54]).
Figure 1 Factors that could determine food selectivity (data taken from the studies of Williams, Schreck and Klein [52,53,54]).CC BY · PubMed Central
Figure 2 Synopsis of ASD food selectivity on nutritional status, anthropometric features and clinical conditions.
Figure 2 Synopsis of ASD food selectivity on nutritional status, anthropometric features and clinical conditions.CC BY · PubMed Central
Figure 3 Role of the gut-brain axis in the etiology of ASD. (1,2) Food that escapes digestion can be used by the gut microbiota bacteria to produce metabolites (e.g., SCFAs and/or 5′-HT) that can be used by the host. Among metabolites (3) 5′-HT is produced particularly by Lactobacillus, Streptococcus, and Lactococcus species, while SCFAs (e.g., propionate) are produced by Clostridia, Bacteroidetes, and Desulfovibrio species. (4) Increased 5′-HT production by the microbiota acts on the metabolism of 5’-HT, leading to tryptophan depletion and contributing to hyperserotonemia, which is associated with GI Symptoms. (5) Intestinal permeability in children with ASD could allow passive diffusion of metabolites, and cause neurodevelopment disorders, such as behavioral and chemical changes (e.g., mood, cognitive state and emotion). (6,7) Moreover, higher intestinal permeability allow the increase in circulating bacteria-derived lipopolysaccharide (LPS), thus stimulating systemic pro-inflammatory cytokines production (e.g., IL-1B, IL-6, IL-8, and IL-12p40), which is associated with impaired social communication. (8) The vagal-mediated signaling from the gut microbiota to the brain can be transmitted through vagal chemoreceptors on mucosal villi that are activated by bacterial metabolites (e.g., 5′-HT, SCFAs) or by vagal mechanoreceptors that sense motility changes induced by bacterial species. (9) Gut microbiota influences the activity of Hypothalamus-Pituitary-Adrenal glands (HPA) axis that increased levels of cortisol in the systemic system. As a consequence, higher levels of cortisol may affect cytokines response and exacerbate GI symptoms.
Figure 3 Role of the gut-brain axis in the etiology of ASD. (1,2) Food that escapes digestion can be used by the gut microbiota bacteria to produce metabolites (e.g., SCFAs and/or 5′-HT) that can be used by the host. Among metabolites (3) 5′-HT is produced particularly by Lactobacillus, Streptococcus, and Lactococcus species, while SCFAs (e.g., propionate) are produced by Clostridia, Bacteroidetes, and Desulfovibrio species. (4) Increased 5′-HT production by the microbiota acts on the metabolism of 5’-HT, leading to tryptophan depletion and contributing to hyperserotonemia, which is associated with GI Symptoms. (5) Intestinal permeability in children with ASD could allow passive diffusion of metabolites, and cause neurodevelopment disorders, such as behavioral and chemical changes (e.g., mood, cognitive state and emotion). (6,7) Moreover, higher intestinal permeability allow the increase in circulating bacteria-derived lipopolysaccharide (LPS), thus stimulating systemic pro-inflammatory cytokines production (e.g., IL-1B, IL-6, IL-8, and IL-12p40), which is associated with impaired social communication. (8) The vagal-mediated signaling from the gut microbiota to the brain can be transmitted through vagal chemoreceptors on mucosal villi that are activated by bacterial metabolites (e.g., 5′-HT, SCFAs) or by vagal mechanoreceptors that sense motility changes induced by bacterial species. (9) Gut microbiota influences the activity of Hypothalamus-Pituitary-Adrenal glands (HPA) axis that increased levels of cortisol in the systemic system. As a consequence, higher levels of cortisol may affect cytokines response and exacerbate GI symptoms.CC BY · PubMed Central

Verification

Claims the paper makes

92 Not checked yet · 11 Own interpretation · 4 No basis given

Verify all 197 references — free account

Show all 50 claims

  • Probably not a substantial claim. 8
  • It may state two separate claims as one. 52
57 of 57
  • The paper relies on this without support.

    Diet induces changes in the intestinal microbiota and in the production of molecules such as short-chain fatty acids (SCFAs).

    “Since the diet induces changes in the intestinal microbiota and in the production of molecules, such as the SCFA, we wanted to investigate the role that nutritional intervention can have on GI microbiota composition and thus on its influence on behavior, GI symptoms and microbiota composition and report which are the beneficial effect on ASD conditions.”
  • The paper relies on this without support.

    Ketogenic diet is associated with higher inflammatory and defective mitochondria risk, and its side effects of constipation and reflux may worsen GI comorbidities in ASD.

    “However, KD is associated with higher inflammatory and defective mitochondria risk and its side effects of constipation and reflux may worsen GI comorbidities in ASD.”
2 of 2

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 202 references

Cited by

Sorted by citations

Metadata

Authors
Ristori, M. V., Quagliariello, A., Reddel, S., Ianiro, G., Vicari, S., Gasbarrini, A., & Putignani, L.
Affiliations
  • Bambino Gesù Children's Hospital (IT)
  • Università Cattolica del Sacro Cuore (IT)
Corresponding author
  • Gasbarrini, Antonio
  • Putignani, Lorenza
Venue
Nutrients
Publisher
MDPI AG
Published
2019-11-18
Volume
11
Issue
11
Pages
2812
ISSN
2072-6643 (ISSN-L)
OpenAlex
W2985368039
Cited by
214
References
202
Citations by year
2026: 20 · 2025: 35 · 2024: 29 · 2023: 38 · 2022: 48 · 2021: 30 · 2020: 13 · 2019: 1
FWCI
2.02
Type
journal article
Language
en
Open access
Locations
  • Nutrients (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Florence Research (University of Florence) (submittedVersion, other-oa)
  • Padua Research Archive (University of Padova) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • PubliCatt (Università Cattolica del Sacro Cuore) (submittedVersion, other-oa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
Keywords
autism spectrum disorder, gastrointestinal symptoms, gut microbiota, dietary intervention, short-chain fatty acids, intestinal permeability, gut-brain axis, dietary factors, picky eating, sensory processing, intestinal infection
MeSH terms
Autism Spectrum Disorder, Gastrointestinal Microbiome, Child, Child Nutritional Physiological Phenomena, Child, Preschool, Diet, Fatty Acids, Volatile, Food Preferences, Gastrointestinal Diseases, Humans, Nutritional Status, Serotonin, Neurotransmitter Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review